Lupus Trial, Recruiting (NCT06887517)

Lupus Trial, Recruiting NCT06887517 Sponsor: Chinese SLE Treatment And Research Group Condition: Lupus

Printed from Voxsanity (voxsanity.com.au) — NCT06887517 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lupus

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with lupus (SLE) according to recognized medical classification systems
Your lupus diagnosis was made 2 years ago or less
Your lupus is considered "non-organ-threatening," meaning it has not seriously affected your kidneys, brain, heart, lungs, eyes, digestive system, or blood in specific severe ways (confirm with trial site for details)
Your lupus is currently showing some level of active symptoms at the time of screening
You have not taken steroid medicines (like prednisone), plasmapheresis, or IVIG treatments in the past 3 months
You have not taken biologic medicines (such as belimumab or TNF-alpha blockers) in the past 3 months
You have not taken cyclophosphamide or certain immune-suppressing medicines (CD20 inhibitors) in the past 6 months

Who may not be able to join:

You have lupus along with another autoimmune condition, such as rheumatoid arthritis, psoriasis, or ankylosing spondylitis
You have another condition (such as asthma or Crohn's disease) that requires you to take steroid medicines
You are pregnant, planning to become pregnant, or currently breastfeeding
Your lupus has seriously affected a major organ, such as your kidneys, heart, or lungs, or you have an uncontrolled infection
You have experienced a blood clot event within the past 3 months (confirm with trial site)
You are unable or unwilling to attend long-term follow-up appointments
The trial doctors believe that participating could put you at significant risk or that you may not be able to complete the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06887517

Sponsor: Chinese SLE Treatment And Research Group

Phase: Not Applicable

Status: Recruiting

Condition: Lupus

More information: https://clinicaltrials.gov/study/NCT06887517

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with lupus (SLE) according to recognized medical classification systems
Your lupus diagnosis was made 2 years ago or less
Your lupus is considered "non-organ-threatening," meaning it has not seriously affected your kidneys, brain, heart, lungs, eyes, digestive system, or blood in specific severe ways (confirm with trial site for details)
Your lupus is currently showing some level of active symptoms at the time of screening
You have not taken steroid medicines (like prednisone), plasmapheresis, or IVIG treatments in the past 3 months
You have not taken biologic medicines (such as belimumab or TNF-alpha blockers) in the past 3 months
You have not taken cyclophosphamide or certain immune-suppressing medicines (CD20 inhibitors) in the past 6 months

Who may not be able to join:

You have lupus along with another autoimmune condition, such as rheumatoid arthritis, psoriasis, or ankylosing spondylitis
You have another condition (such as asthma or Crohn's disease) that requires you to take steroid medicines
You are pregnant, planning to become pregnant, or currently breastfeeding
Your lupus has seriously affected a major organ, such as your kidneys, heart, or lungs, or you have an uncontrolled infection
You have experienced a blood clot event within the past 3 months (confirm with trial site)
You are unable or unwilling to attend long-term follow-up appointments
The trial doctors believe that participating could put you at significant risk or that you may not be able to complete the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Chinese SLE Treatment And Research Group

Registry

ClinicalTrials.gov

Start date

10 February 2025

Est. completion

1 April 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Occurrence of major organ involvement in SLE

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov